PubRank

M A Sande

Author PubWeight™ 320.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997 8.24
2 Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 1998 8.02
3 Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992 6.30
4 Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989 6.29
5 A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med 1979 5.87
6 Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989 5.66
7 Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother 1974 5.19
8 Sexual harassment in medical training. N Engl J Med 1993 4.93
9 Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis 1979 4.70
10 Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest 1978 4.38
11 Role of toxigenic and invasive bacteria in acute diarrhea of childhood. N Engl J Med 1975 4.23
12 Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001 3.75
13 Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis 1975 3.52
14 Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis 1975 3.33
15 Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001 3.15
16 Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med 1980 3.03
17 Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001 2.87
18 Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. J Infect Dis 1984 2.77
19 Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991 2.77
20 Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. J Infect Dis 1974 2.64
21 Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med 1989 2.58
22 Sinusitis of the maxillary antrum. N Engl J Med 1975 2.57
23 Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med 1982 2.52
24 Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis 1987 2.32
25 Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989 2.18
26 Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001 2.17
27 Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med 1991 2.12
28 Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 1985 2.10
29 Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 1991 2.07
30 The HIV epidemic and training in internal medicine. Challenges and recommendations. N Engl J Med 1989 2.06
31 Uncomplicated acute bronchitis. Ann Intern Med 2000 2.06
32 Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis 1975 2.05
33 A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. Am J Med 1998 2.04
34 Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA 1989 2.03
35 Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J Infect Dis 1984 2.00
36 Methods to improve detection of pneumococci in respiratory secretions. J Clin Microbiol 1975 1.94
37 Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest 1983 1.93
38 Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. J Infect Dis 1988 1.90
39 In vitro susceptibility studies with josamycin and erythromycin. Antimicrob Agents Chemother 1976 1.89
40 Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med 2001 1.89
41 Role of the vegetation in experimental Streptococcus viridans endocarditis. Infect Immun 1974 1.89
42 Multiple use of disposable insulin syringe-needle units. JAMA 1980 1.89
43 Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis 1975 1.88
44 Routine use of anaerobic blood cultures: are they still indicated? Am J Med 2000 1.88
45 Comparative pharmacology of cefaclor and cephalexin. Antimicrob Agents Chemother 1977 1.86
46 Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother 1985 1.85
47 Opportunistic pneumonia: a clinicopathological study of five cases caused by an unidentified acid-fast bacterium. N Engl J Med 1979 1.84
48 Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother 1984 1.75
49 Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother 1975 1.75
50 Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J Lab Clin Med 1976 1.73
51 Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. Infect Immun 1983 1.72
52 Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother 1986 1.70
53 Cephalosporin antibiotics in therapy of experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis in rabbits. J Infect Dis 1978 1.68
54 The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. J Infect Dis 1984 1.67
55 Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis 1985 1.66
56 Candida albicans endocarditis: ultrastructural studies of vegetation formation. Infect Immun 1978 1.66
57 Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency. Antimicrob Agents Chemother 1981 1.66
58 New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother 1985 1.66
59 Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J Clin Invest 1980 1.64
60 Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med 1984 1.64
61 Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J Infect Dis 1979 1.57
62 Experimental Candida albicans endocarditis: characterization of the disease and response to therapy. Infect Immun 1977 1.56
63 Value of serum tests in combined drug therapy of endocarditis. Antimicrob Agents Chemother 1983 1.56
64 Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 2001 1.55
65 Sustained bacteremia in patients with prosthetic cardiac valves. N Engl J Med 1972 1.54
66 Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis 1979 1.52
67 Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects. Antimicrob Agents Chemother 1981 1.51
68 In vitro susceptibility studies with cefaclor and cephalexin. Antimicrob Agents Chemother 1977 1.51
69 Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis 1981 1.49
70 Comparative pharmacology of josamycin and erythromycin stearate. Antimicrob Agents Chemother 1976 1.46
71 Cefamandole and ampicillin therapy in experimental Haemophilus influenzae meningitis. J Infect Dis 1977 1.46
72 Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J Clin Invest 1984 1.46
73 Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis 1992 1.41
74 Effect of fibronectin on adherence of Staphylococcus aureus to fibrin thrombi in vitro. Infect Immun 1985 1.40
75 Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. Medicine (Baltimore) 1983 1.39
76 Antibiotic therapy of bacterial meningitis: lessons we've learned. Am J Med 1981 1.38
77 Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Emerg Med 2001 1.37
78 Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis. Antimicrob Agents Chemother 1983 1.37
79 Influence of preformed antibody on experimental Streptococcus sanguis endocarditis. Infect Immun 1979 1.36
80 Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. J Infect Dis 1978 1.36
81 Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Antimicrob Agents Chemother 1980 1.34
82 Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis 1987 1.33
83 Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits. J Clin Invest 1981 1.31
84 Etiology and antimicrobial treatment of acute sinusitis. Ann Otol Rhinol Laryngol Suppl 1981 1.30
85 Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J Infect Dis 1988 1.29
86 Providencia stuartii, a hospital pathogen: potential factors for its emergence and transmission. Am J Epidemiol 1976 1.28
87 Influence of the developmental state of valvular lesions on the antimicrobial activity of cefotaxime in experimental enterococcal infections. Antimicrob Agents Chemother 1985 1.28
88 Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother 1986 1.27
89 High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 2001 1.26
90 The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990 1.25
91 Swine-influenza infection in civilians. Report of two cases. N Engl J Med 1976 1.23
92 Diagnosis of pneumococcal pneumonia by antigen detection in sputum. J Clin Microbiol 1978 1.22
93 Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis. J Lab Clin Med 1977 1.21
94 Rapid identification of pneumococci. Gram stain vs. the quellung reaction. N Engl J Med 1973 1.21
95 Penicillin-netilmicin synergism against Streptococcus faecalis. Antimicrob Agents Chemother 1978 1.19
96 Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis. Antimicrob Agents Chemother 1978 1.18
97 Transmission of AIDS. The case against casual contagion. N Engl J Med 1986 1.18
98 Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis. Antimicrob Agents Chemother 1982 1.18
99 Pathogenesis of endocarditis. Am J Med 1985 1.17
100 Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis. Antimicrob Agents Chemother 1985 1.16
101 Effect of rifampin on nasal carriage of Staphylococcus aureus. Antimicrob Agents Chemother 1975 1.16
102 Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Emerg Med 2001 1.14
103 The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992 1.12
104 Serotypes of Cryptococcus neoformans in patients with AIDS. J Infect Dis 1986 1.11
105 Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitis. Infect Immun 1979 1.10
106 Loss of cerebrovascular autoregulation in experimental meningitis in rabbits. J Clin Invest 1990 1.10
107 Principles in the treatment of bacterial meningitis. Am J Med 1984 1.09
108 In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice. J Infect Dis 1973 1.08
109 Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. J Antimicrob Chemother 1986 1.07
110 Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function. Antimicrob Agents Chemother 1978 1.06
111 The use of rifampin in the treatment of nontuberculous infections: an overview. Rev Infect Dis 1983 1.06
112 Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs. Antimicrob Agents Chemother 1985 1.05
113 Dexamethasone in bacterial meningitis: increasing evidence for a beneficial effect. Pediatr Infect Dis J 1989 1.05
114 Ventriculojugular shunt nephritis with Corynebacterium bovis. Successful therapy with antibiotics. Am J Med 1975 1.05
115 Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother 1989 1.04
116 Skeletal muscle in idiopathic cardiomyopathy. J Neurol Sci 1972 1.03
117 Rifampin in experimental endocarditis due to Staphylococcus aureus in rabbits. Rev Infect Dis 1983 1.03
118 Evaluation of cefamandole therapy of patients with bacterial meningitis. J Infect Dis 1978 1.03
119 Adult toxoplasmosis presenting as polymyositis and cerebellar ataxia. Ann Intern Med 1975 1.03
120 Pharmacodynamics of cefazolin in the presence of normal and impaired renal function. Antimicrob Agents Chemother 1973 1.02
121 Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis. Infect Immun 1984 1.02
122 Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome. J Infect Dis 1996 1.01
123 Transmission of hepatitis B without transmission of AIDS by accidental needlestick. N Engl J Med 1985 1.01
124 In vitro antibiotic susceptibility of salmonellae. Antimicrob Agents Chemother 1977 1.01
125 Reconsideration of rifampin: a unique drug for a unique infection. JAMA 1998 1.01
126 Enzyme-linked immunosorbent assay for detection of Streptococcus pneumoniae antigen. J Clin Microbiol 1979 1.01
127 Antimicrobial activity of gentamicin in experimental enterococcal endocarditis. Antimicrob Agents Chemother 1985 1.01
128 Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli. Am J Med 1977 0.99
129 Ampicillin and an ester in experimental Hemophilus influenzae meningitis. Clin Pharmacol Ther 1976 0.99
130 Identification of procedure-related nosocomial infections in high-risk patients. Rev Infect Dis 1982 0.98
131 Cryptococcal meningitis in the acquired immunodeficiency syndrome. Semin Respir Infect 1990 0.98
132 Factors influencing the penetration and activity of antibiotics in experimental meningitis. J Infect 1981 0.97
133 Cefamandole in the therapy of experimental pneumococcal meningitis. J Antimicrob Chemother 1976 0.97
134 Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs. J Infect Dis 1984 0.95
135 Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. Antimicrob Agents Chemother 1992 0.95
136 Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits. Infect Immun 1986 0.95
137 Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination. JAMA 1973 0.94
138 Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies. Am J Med 1983 0.93
139 Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases. Rev Infect Dis 1983 0.93
140 Diarrhea and AIDS in the era of highly active antiretroviral therapy. Clin Infect Dis 1999 0.93
141 Point source epidemic of Mycoplasma pneumoniae infection in a prosthodontics laboratory. Am Rev Respir Dis 1975 0.92
142 AIDS and the elderly. Clin Infect Dis 1999 0.92
143 Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis. J Clin Invest 1992 0.92
144 Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob Agents Chemother 1985 0.92
145 Ciprofloxacin for Salmonella bacteremia in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989 0.91
146 Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis. Antimicrob Agents Chemother 1979 0.91
147 Landmark perspective: The impact of penicillin on the treatment of meningitis. JAMA 1984 0.91
148 Fluid administration, brain edema, and cerebrospinal fluid lactate and glucose concentrations in experimental Escherichia coli meningitis. J Infect Dis 1993 0.90
149 Clindamycin therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 1982 0.90
150 General principles of therapy of pyogenic meningitis. Infect Dis Clin North Am 1990 0.90
151 Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis. Infect Immun 1983 0.89
152 Double-blind comparison of carbenicillin indanyl sodium, ampicillin, and cephalexin in treatment of urinary tract infection. Antimicrob Agents Chemother 1973 0.89
153 The abilities of a Staphylococcus epidermidis wild-type strain and its slime-negative mutant to induce endocarditis in rabbits are comparable. Infect Immun 1998 0.89
154 Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Emerg Med 2001 0.88
155 Combination antifungal chemotherapy for experimental disseminated candidiasis: lack of correlation between in vitro and in vivo observations with amphotericin B and rifampin. Rev Infect Dis 1983 0.88
156 Novel approaches for the use of aminoglycosides: the value of experimental models. J Antimicrob Chemother 1986 0.88
157 Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection. J Antimicrob Chemother 1985 0.88
158 Penetration of antistaphylococcal antibiotics into the human eye. Am J Ophthalmol 1974 0.88
159 Moxalactam for the treatment of bacterial meningitis in children. J Infect Dis 1983 0.87
160 Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death. J Infect Dis 1994 0.87
161 Evaluation of pefloxacin in experimental Escherichia coli meningitis. Antimicrob Agents Chemother 1986 0.86
162 Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Emerg Med 2001 0.86
163 Osteomyelitis caused by concurrent infection with Mycobacterium tuberculosis and Blastomyces dermatitidis. Am Rev Respir Dis 1974 0.86
164 Moxalactam therapy vs. standard antimicrobial therapy for selected serious infections. Rev Infect Dis 1983 0.86
165 Detection of circulating antigen in experimental Candida albicans endocarditis by an enzyme-linked immunosorbent assay. J Clin Microbiol 1980 0.85
166 Bacteremia associated with cardiac catheterization. N Engl J Med 1969 0.85
167 Comparative penetration of six antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis. J Antimicrob Chemother 1980 0.84
168 Pulmonary infection with capsule-deficient cryptococcus neoformans. Virchows Arch A Pathol Anat Histol 1979 0.84
169 Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Emerg Med 2001 0.84
170 The use of rifampicin in staphylococcal infections--a review. J Antimicrob Chemother 1984 0.84
171 Treatment of infective endocarditis due to viridans streptococci, This statement was prepared by the ad hoc subcommittee on Treatment of Bacterial endocarditis of the American Heart Association Council on Cardiovascular Disease in the Young. Circulation 1981 0.84
172 Global descriptive evaluations are more responsive than global numeric ratings in detecting students' progress during the inpatient portion of an internal medicine clerkship. Acad Med 2001 0.83
173 Clinical aspects of adult epiglottitis. West J Med 1986 0.83
174 Effects of sub-bactericidal concentrations of antibiotics in experimental models of endocarditis. J Antimicrob Chemother 1985 0.82
175 Factors influencing the pathogenesis and prevention of infective endocarditis. Scand J Infect Dis Suppl 1982 0.82
176 A rapid method of disinfecting the bronchofiberscope. Am Rev Respir Dis 1976 0.82
177 Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals. J Infect Dis 1985 0.82
178 Mechanism of anaemia in experimental bacterial endocarditis. Scand J Haematol 1975 0.82
179 Factors influencing the penetration of antimicrobial agents into the cerebrospinal fluid of experimental animals. Scand J Infect Dis Suppl 1978 0.81
180 Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysis. Antimicrob Agents Chemother 1982 0.81
181 Cefamandole treatment of pulmonary infection caused by gram-negative rods. J Antimicrob Chemother 1976 0.81
182 The pharmacokinetics of teicoplanin in varying degrees of renal function. Clin Pharmacol Ther 1990 0.80
183 Challenging conventional aminoglycoside dosing regimens. The value of experimental models. Am J Med 1986 0.80
184 Evaluation of combination chemotherapy in a lightly anesthetized animal model of Pseudomonas pneumonia. Antimicrob Agents Chemother 1987 0.80
185 Yeast adherence in the pathogenesis of Candida endocarditis. Proc Soc Exp Biol Med 1981 0.79
186 Antimicrobial therapy for two serious bacterial infections. Enterococcal endocarditis and nosocomial pneumonia. Arch Intern Med 1982 0.79
187 Limitations of animal models in predicting beta-lactam efficacy for endocarditis and meningitis. Rev Infect Dis 1986 0.79
188 Cefotetan and coagulopathy. J Infect Dis 1989 0.79
189 Antibiotic penetration into normal and inflamed tissues as reflected by peripheral lymph. Ann Surg 1979 0.79
190 Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia. Am J Med 1987 0.79
191 Effect of indomethacin on the pathophysiology of experimental meningitis in rabbits. J Infect Dis 1991 0.78
192 The influence of dosing schedules and cerebrospinal fluid bactericidal activity on the therapy of bacterial meningitis. J Antimicrob Chemother 1985 0.78
193 A multivariate approach to prognostication in experimental bacterial meningitis. Am J Clin Pathol 1981 0.78
194 Antibiotic combinations in experimental infections in animals. Rev Infect Dis 1982 0.78
195 Ciprofloxacin in the treatment of Helicobacter pylori in patients with gastritis and peptic ulcer. J Infect Dis 1990 0.78
196 Evaluation of antimicrobial agents in the rabbit model of endocarditis. Rev Infect Dis 1982 0.77
197 Role of platelets in endocarditis: clues from von Willebrand disease. J Lab Clin Med 1992 0.77
198 Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992 0.77
199 Serum bactericidal titer as a predictor of outcome in endocarditis. Eur J Clin Microbiol 1986 0.77
200 Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis. Am J Med 1984 0.77
201 Amdinocillin therapy of experimental animal infections. Am J Med 1983 0.76
202 New cephalosporin antibiotics: selection and uses. Hosp Formul 1985 0.76
203 Alterations in cerebrospinal fluid outflow resistance in experimental bacterial meningitis. Trans Am Neurol Assoc 1978 0.76
204 Cerebrospinal fluid prognostic indices in experimental pneumococcal meningitis. J Lab Clin Med 1982 0.76
205 Simultaneous disseminated aspergillosis and zygomycosis in a leukemic patient. South Med J 1979 0.76
206 Tuberculosis and human immunodeficiency virus disease. West J Med 1994 0.75
207 Evaluation of new anti-infective drugs for the treatment of viral encephalitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992 0.75
208 Making drugs work against HIV. Hosp Pract (1995) 1996 0.75
209 Patterns of antibiotic use in a busy metropolitan emergency room: analysis of efficacy and cost-appropriateness. West J Med 1983 0.75
210 Pathogenesis of bacterial meningitis: contributions by experimental models in rabbits. Infection 1984 0.75
211 Diagnosis and outcome of bowel infarction on an acute medical service. Am J Med 1983 0.75
212 Single-dose ampicillin/sulbactam versus ceftriaxone as treatment for uncomplicated gonorrhoea in a Ugandan STD clinic population with a high prevalence of PPNG infection. J Trop Med Hyg 1995 0.75
213 Evaluation of methods for determining antibacterial activity of serum and urine after colistimethate injection. Clin Pharmacol Ther 1971 0.75
214 Pharmacodynamics of antibiotics in experimental bacterial meningitis--two sides to rapid bacterial killing in the cerebrospinal fluid. Scand J Infect Dis Suppl 1990 0.75
215 AIDS: An introduction. Bull N Y Acad Med 1988 0.75
216 Hemodynamic characteristics of patients with hypothermia due to occult infection and other causes. Ann Intern Med 1985 0.75
217 Some newer aspects of infective endocarditis. Geriatrics 1975 0.75
218 Controlled penicillin anaphylaxis leading to desensitization. South Med J 1974 0.75
219 Evaluation of FCE 22101 in experimental meningitis caused by Escherichia coli and Streptococcus pneumoniae. J Antimicrob Chemother 1989 0.75
220 Inhibition of isolation of Escherichia coli in blood cultures by trimethoprim-sulfamethoxazole. J Infect Dis 1983 0.75
221 Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis. JAMA 1976 0.75
222 The need for controlled clinical studies in antimicrobial therapy. Ann Intern Med 1978 0.75
223 Experimental models of CNS infections. Contributions to concepts of disease and treatment. Neurol Clin 1986 0.75
224 Developing strategies for the future of academic public hospitals. Am J Med 1996 0.75
225 Aspiration during sleep. JAMA 1973 0.75
226 Acute bronchitis in the healthy adult. Curr Clin Top Infect Dis 2000 0.75
227 Experimental endocarditis in calf after tricuspid valve replacement. Ann Thorac Surg 1980 0.75
228 Evaluation of new anti-infective drugs for the treatment of cryptococcal meningitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992 0.75
229 Left atrial tumor presenting with hemoptysis and pulmonary infiltrates. Am Rev Respir Dis 1970 0.75
230 Outcome for hospitalized patients with fever and neutropenia who are infected with the human immunodeficiency virus. Clin Infect Dis 1995 0.75
231 Oral SCH 39304 as primary, salvage, and maintenance therapy for cryptococcal meningitis in AIDS. J Acquir Immune Defic Syndr 1992 0.75
232 AIDS: questions and controversies--a panel discussion. Semin Hematol 1987 0.75
233 [HIV infection and tuberculosis]. Dtsch Med Wochenschr 1991 0.75
234 Antibiotic penetration into normal and inflamed tissues as reflected by peripheral lymph. Surg Forum 1977 0.75
235 Bacterial adherence in endocarditis: interaction of bacterial dextran, platelets, fibrin, and antibody. Scand J Infect Dis Suppl 1980 0.75
236 Infectious Diseases Society of America and health care reform. Clin Infect Dis 1994 0.75
237 Cholestasis and disseminated cytomegalovirus disease in patients with the acquired immunodeficiency syndrome. Am J Med 1988 0.75
238 Otitis media: a review. Va Med 1977 0.75
239 Controversies in the diagnosis and management of infectious diseases. Session III: AIDS. Summary and discussion. Rev Infect Dis 1987 0.75